• Bextra®
• Alert
• Alternative
• Attorney
• Claim
• Class Action
• Complications
• Danger
• Depression
• Dosage
• Effects
• Heart
• Information
• Injury
• Lawsuit
• Litigation
• Medication
• Problems
• Reaction
• Recall
• Risks
• Safety
• Stroke
• Warnings
• Contact a Lawyer

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Bextra® heart safety has been a controversial issue since the recall of a similar drug called Vioxx® on September 30, 2004. Bextra® and Vioxx® are COX-2 selective non-steroidal anti-inflammatory pain medications approved to treat the severe pain associated with osteoarthritis, rheumatoid arthritis, and menstrual cramps.

Vioxx®''s manufacturer, Merck, voluntarily pulled their pain medication off the market after internal studies found that taking Vioxx® for eighteen months doubles a patient''s risk of suffering from a heart attack or stroke. These findings have prompted Bextra® heart safety scrutiny and worries that Bextra® use may also cause an increased risk of heart problems or stroke in patients. The cardiovascular safety of all COX-2 selective pain medications has been the recent subject of nationwide concern.

Bextra® heart and stoke risks were discussed at an American Heart Association meeting in New Orleans in early November of 2004. At this meeting a study was presented that indicated Bextra® heart problems may be a possible side effect of taking this medication. Patients who were taking Bextra® at the time they underwent cardiac bypass surgery had a higher risk of suffering heart complications than other surgery patients.

Pfizer, Bextra®''s maker, responded to these reports by claiming that these findings were unsubstantiated because they have not been published in medical journals or confirmed by independent research. Pfizer has recently announced plans to conduct long term studies on Bextra® heart problem and stroke risks. The Food and Drug Administration claims that they too will be conducting studies on Bextra® heart safety and the cardiovascular safety of all COX-2 selective pain medications.

It is still unclear whether Bextra® heart problems and stroke are potential side effects of this medication. If you begin to experience any heart attack or stroke symptoms while taking Bextra®, you should seek immediate medical attention. Symptoms of stroke may include sudden weakness or numbness to one side of the body, disorientation and confusion, loss of coordination, blurred vision, and troubles with walking, speaking and understanding others. Symptoms of Bextra® heart problems can include chest pains, shortness of breath or difficulty breathing, edema (tissue swelling), excessive fatigue or weakness, persistent coughing, appetite changes, and confusion

In addition to the possible risks associated with Bextra® heart safety, Bextra® is known to cause rare but serious side effects. Severe skin conditions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis are possible Bextra® side effects. Anaphylactic shock and allergic reactions are also possible side effects associated with Bextra® use.

If you are taking Bextra® and have experienced Bextra® heart problems, stroke or any other adverse health conditions, you may be eligible to seek compensation for your damages through a product liability Bextra® lawsuit. Recovery of medical expenses, loss of income, and pain and suffering may be possible through a civil claim as well.

"Bextra Suit Filed"

Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.

Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...

» Read More

"FDA issues drug warnings on its Web site"

The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...

» Read More

"FDA to listen to outside advisers in hopes of improving drug-monitoring system"

After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...

» Read More

• Accutane® |
• Acetaminophen |
• Actavis Information |
• Actos® |
• Amiodarone |
• Trasylol® - Aprotinin Injection |
• Avandia® |
• Baycol® |
• Bextra® |
• Botox |
• Byetta® |
• Celebrex |
• Cellcept |
• Chantix® |
• Cipro Side Effects |
• Crestor |
• Darvocet |
• Darvon® |
• Defective Drug FAQ |
• Common Defective Drugs |
• Depakote® |
• Drug Company Information |
• Defective Drug Side Effects |
• Duragesic Patch |
• Exjade |
• Fentanyl |
• Fen Phen |
• Fleet Phospho Soda |
• Fluoroquinolone Antibiotics |
• Fosamax |
• Gadolinium |
• Gardasil |
• Gleevec |
• Heparin |
• Humira and Remicade |
• Hydroquinone |
• Hydroxycut |
• Januvia® and Janumet® Information |
• Kava Kava |
• Ketek |
• Lariam |
• Levaquin |
• Lupron (Leuprolide) |
• Meridia |
• Multaq® |
• Naproxen (Aleve) |
• Natrecor |
• Neurontin |
• Nexium® (Esomeprazole Magnesium) Heartburn Relief |
• NuvaRing® |
• Ocella Information |
• Osteonecrosis and Fosamax |
• Oxycontin |
• Palladone |
• Paxil |
• Permax |
• Plavix |
• PPA |
• Pradaxa® |
• Prevacid® |
• Prilosec® |
• Procrit |
• Propecia® (Finasteride) |
• Propoxyphene |
• Protonix® |
• Protopic |
• Prozac |
• What is Quinine? |
• Rapamune® Lawyer |
• Raptiva |
• Reglan |
• Remicade Lawsuit |
• Rezulin |
• Risperdal |
• Ritalin |
• Serevent |
• Seroquel |
• Serzone |
• Tequin |
• Thimerosal |
• Topamax® (Topiramate) |
• Viagra® |
• Wellbutrin® |
• Xenical |
• Yasmin® |
• Yaz Birth Control Lawyer |
• Zelnorm |
• Zocor® Medication Information |
• Zoloft |
• Zyprexa |